Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy.

COVID-19 NIV SARS-CoV2 drugs injury liver

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
26 Jan 2022
Historique:
received: 31 12 2021
revised: 21 01 2022
accepted: 23 01 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 27 2 2022
Statut: epublish

Résumé

Patients with COVID-19 show a high prevalence of liver injury. The pattern of this liver damage is still not fully understood. Different etiopathogenetic factors may concur; from a direct cytopathic effect, once the virus binds to the ACE-2 receptors, to the immune-mediated collateral damage, due to cytokine storm. The presence of pre-existing chronic liver disease is a contributing factor for acute organ damage during SARS-CoV2 infection. Last but not least, treatments probably play a role, also, in determining hepatotoxicity: many of the drugs we have used or are still using to treat COVID-19, combined with non-invasive ventilation, are known to sometimes determine acute liver injury. Although liver damage associated with COVID-19 is often transient and can resolve without any special treatment, it is important to understand the underlying mechanisms, particularly to better treat its more severe forms.

Identifiants

pubmed: 35214651
pii: vaccines10020192
doi: 10.3390/vaccines10020192
pmc: PMC8880796
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Hepatol. 2020 Oct;73(4):807-816
pubmed: 32437830
N Engl J Med. 2020 Dec 3;383(23):2255-2273
pubmed: 33264547
Infection. 2022 Feb;50(1):27-41
pubmed: 34331674
Clin Liver Dis. 2007 Aug;11(3):525-48, vi
pubmed: 17723918
Cureus. 2020 Jul 27;12(7):e9424
pubmed: 32864250
Crit Care. 2020 May 6;24(1):198
pubmed: 32375845
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430
pubmed: 32145190
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Circulation. 2006 Apr 18;113(15):e698-702
pubmed: 16618822
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
N Engl J Med. 2021 Aug 26;385(9):790-802
pubmed: 34351721
Aliment Pharmacol Ther. 2007 May 15;25(10):1135-51
pubmed: 17451560
JAMA. 2021 May 4;325(17):1731-1743
pubmed: 33764378
J Clin Med. 2021 Sep 28;10(19):
pubmed: 34640480
Lancet. 2021 May 01;397(10285):1637-1645
pubmed: 33933206
JAMA Intern Med. 2021 Jan 1;181(1):24-31
pubmed: 33080005
Therapie. 2020 Jul - Aug;75(4):355-362
pubmed: 32418728
Gastroenterology. 2015 Jun;148(7):1340-52.e7
pubmed: 25754159
Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1174-1181
pubmed: 30112779
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Front Immunol. 2020 Jun 16;11:1446
pubmed: 32612617
Infect Dis Ther. 2022 Feb;11(1):231-248
pubmed: 34757578
Physiol Genomics. 2020 Nov 1;52(11):549-557
pubmed: 32991251
Pharmacotherapy. 2020 Aug;40(8):843-856
pubmed: 32542785
Drug Ther Bull. 2020 May;58(5):69
pubmed: 32234728
J Steroid Biochem Mol Biol. 2015 Nov;154:94-103
pubmed: 26241028
Respirology. 2021 Nov;26(11):1027-1040
pubmed: 34605114
Respir Med. 2021 Mar;178:106323
pubmed: 33545499
Intensive Care Med. 1996 Nov;22(11):1274-5
pubmed: 9120128
BMJ. 2021 Oct 14;375:n2400
pubmed: 34649864
J Hepatol. 2019 Jun;70(6):1222-1261
pubmed: 30926241
Clin Med (Lond). 2016 Dec;16(Suppl 6):s104-s109
pubmed: 27956449
Lancet Respir Med. 2021 Dec;9(12):1407-1418
pubmed: 34480861
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
J Clin Pharmacol. 2020 Dec;60(12):1671-1678
pubmed: 32639644
Dig Liver Dis. 2021 Feb;53(2):158-165
pubmed: 32873520
Nat Med. 2021 Oct;27(10):1752-1760
pubmed: 34480127
Drug Saf. 2020 Aug;43(8):691-698
pubmed: 32696429
Infection. 2021 Aug;49(4):591-605
pubmed: 33709380
Hum Vaccin Immunother. 2017 Sep 2;13(9):1972-1988
pubmed: 28841363
Eur Respir Rev. 2021 Oct 20;30(162):
pubmed: 34670808
Expert Rev Anti Infect Ther. 2021 Sep 29;:1-10
pubmed: 34538216
Curr Drug Metab. 2018;19(10):830-838
pubmed: 29788883
Arthritis Rheum. 2003 Apr;48(4):927-34
pubmed: 12687534
J Dig Dis. 2019 Mar;20(3):122-126
pubmed: 30582289
Saudi Pharm J. 2020 Nov;28(11):1326-1332
pubmed: 32904846
Int Immunopharmacol. 2016 Nov;40:318-326
pubmed: 27664570
Pharmacotherapy. 2001 Jan;21(1):108-13
pubmed: 11191729
Adv Pharmacol. 2019;85:263-272
pubmed: 31307590
New Horiz. 1994 Nov;2(4):488-504
pubmed: 7804798
J Clin Epidemiol. 1993 Nov;46(11):1331-6
pubmed: 8229111
Crit Care. 2021 Jul 30;25(1):268
pubmed: 34330320
NPJ Genom Med. 2020 Aug 18;5:35
pubmed: 32864162
Biochem Biophys Res Commun. 2020 May 21;526(1):135-140
pubmed: 32199615
N Engl J Med. 2021 Aug 26;385(9):777-789
pubmed: 34351722
Int J Antimicrob Agents. 2020 Aug;56(2):106053
pubmed: 32534189
Med Mal Infect. 2020 Jun;50(4):384
pubmed: 32240719
Cornea. 2019 Jan;38(1):123-126
pubmed: 30371567
Intensive Care Med. 2006 Feb;32(2):267-274
pubmed: 16450099
Arch Toxicol. 2020 Oct;94(10):3381-3407
pubmed: 32852569
Crit Care. 2007;11(1):R13
pubmed: 17261192
Drug Saf Case Rep. 2015 Dec;2(1):17
pubmed: 27747729
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):112-121
pubmed: 28379588
Gut. 2021 Apr;70(4):733-742
pubmed: 32641471
Front Pharmacol. 2019 Jul 23;10:730
pubmed: 31396080
Am J Med Sci. 2021 Nov 6;:
pubmed: 34752741
Hepatol Int. 2020 Sep;14(5):711-722
pubmed: 32623633
Clin Infect Dis. 2021 May 4;72(9):e373-e381
pubmed: 32785710
Clin Exp Pharmacol Physiol. 2020 Aug 7;:
pubmed: 32767405
Gut. 2005 Dec;54(12):1790-6
pubmed: 16166274
JAMA. 2003 Sep 17;290(11):1505-9
pubmed: 13129992
Int J Antimicrob Agents. 2020 Aug;56(2):106024
pubmed: 32450197
Biochimie. 2020 Dec;179:266-274
pubmed: 32891697
J Med Internet Res. 2020 Aug 13;22(8):e20193
pubmed: 32707537
JAMA. 2021 Apr 27;325(16):1620-1630
pubmed: 33734299
Int J Antimicrob Agents. 2020 Oct;56(4):106143
pubmed: 32853672
Respir Res. 2020 Dec 1;21(1):318
pubmed: 33261606
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Minerva Med. 2021 Oct 21;:
pubmed: 34672164
Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3
pubmed: 25111234
N Engl J Med. 2020 Nov 19;383(21):2041-2052
pubmed: 32706953
Hepatol Commun. 2020 Mar 13;4(5):631-645
pubmed: 32363315
Endocrinol Diabetes Metab Case Rep. 2019 Sep 27;2019:
pubmed: 31600730
Semin Liver Dis. 2002;22(2):185-94
pubmed: 12016549
Eur Respir J. 2017 Sep 10;50(3):
pubmed: 28890434
Clin Liver Dis. 2012 May;16(2):231-45
pubmed: 22541696
Ann Gastroenterol. 2016 Oct-Dec;29(4):454-459
pubmed: 27708510
Clin Pharmacol Ther. 2012 Aug;92(2):214-20
pubmed: 22739141
Expert Rev Gastroenterol Hepatol. 2020 Oct;14(10):873-876
pubmed: 32643980
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204

Auteurs

Maurizio Gabrielli (M)

Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Laura Franza (L)

Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Alessandra Esperide (A)

Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Irene Gasparrini (I)

Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Antonio Gasbarrini (A)

Department of Medical and Surgical Science, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Università Cattolica del Sacro Cuore di Roma, Largo A. Gemelli 8, 00168 Rome, Italy.

Francesco Franceschi (F)

Department of Emergency, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Classifications MeSH